Intra-ovarian injection of platelet-rich plasma in patients with poor ovarian response

Not Applicable

Recruiting

• Conditions: Decreased ovarian reserve.; Female infertility, unspecified; N97.9

• Registration Number: IRCT20080831001141N40
• Lead Sponsor: ROYAN Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Patients with a history of at least one poor ovarian response
Age =44 years
BMI <35 kg/m2
FSH <25 IU/L
AMH <1.2 ng/ml

Exclusion Criteria

Endocrine, autoimmune and hematological disorders
Genetic diseases and chromosomal disorders
History of cancer
Congenital uterine anomalies
Endometriosis, severe adenomyosis, hydrosalpinx, fibromatous uterus

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increased ovarian reserve: increased number of antral follicles, and increased levels of antimullerin hormone. Timepoint: 6-8 weeks after intraovarian injection of platelet-rich plasma. Method of measurement: Doppler ultrasound and blood test.